Click to enlarge

S-ZOL contains 30 mg Stanozolol in a 5 g gel sachet for oral administration. The anabolic / androgenic steroid, stanozolol (known worldwide under the trade name, “Winstrol Depot”) belongs to the group of dihydrotestosterone derivatives. Despite its close relationship with dihydrotestosterone, the strongest natural androgen, stanozolol possesses only a very mild androgenic effect. According to the Summary of Product Characteristics, its androgenicity is quoted as approximately 30% of that of the reference steroid, methyltestosterone. In contrast, stanozolol has a 320% greater anabolic effect than methyltestosterone. As a dihydrotestosterone derivative, stanozolol cannot be converted into oestrogens and has no progesterone effect, thus excluding fat and water accumulation during use. Furthermore, stanozolol works as an aldosterone antagonist and thus possesses draining properties. These properties make stanozolol a popular steroid during dieting and for building up high quality muscle mass. The product, which is available in the form of tablets or capsules for oral administration, should not be taken for more than eight weeks due to the alpha-17-alkylation of the active substance, which is potentially harmful for the liver. The current dosage of stanozolol is 25 – 50 mg per day or on alternate days, depending on the desired effect and the user’s experience. Detailed treatment plans are given at http://sledge-hammer.com/stacks/Stacks_en.pdf. The S-ZOL (Stanozolol 30 mg) gel for oral administration is a newcomer to the international stage. It contains the active substance, stanozolol, at a dose of 30 mg per gel sachet. Stanozolol is contained in a special carrier gel, which, on oral administration, releases the active substance directly onto the oral mucosa. Buccal (absorption through the cheek mucosa) or sublingual (absorption through the tongue mucosa) administration of the gel is recommended as this offers advantages that are not available with normal oral dosing, e.g. by swallowing a tablet or capsule. If the gel is held for at least one minute under the tongue (sublingual) or in the cheek (buccal), the stanozolol it contains is mostly (> 50 %) released directly into the upper vena cava via the blood vessels in the oral mucosa, thus leading to the right side of the heart. The first-pass effect through the liver, which partially deactivates the active substance and which is consequently exposed to a high load, is for the most part, avoided. The known side effects of a dysfunctional liver such as upper abdominal and digestive disorders, loss of appetite and fatigue as well as an increase in blood lipid values can be substantially reduced by S-ZOL. Stanozolol is not biochemically altered following sublingual or buccal administration and is thus fully available to the body after dosing. Another advantage of absorption through the oral mucosa is the accelerated uptake of the active substance in the blood. This is important in order to quickly build up effective stanozolol levels in the blood. A consistently high active substance level can be maintained with two daily doses. This is not feasible with tablets due to variable solubility and partial deactivation of stanozolol following first pass effect in the liver. The rapid onset of efficacy with S-ZOL sharpens mental focus and physical performance increases after the first dose. The novel pharmaceutical form in small gel sachets is a recent and extremely important advantage for distributors and end users alike. The gel sachets are small, flat, unobtrusive and not only can they be easily transported by end users but they are inconspicuous on receipt. Gone are the days when people received packets of rattling tablets. A gel sachet doesn’t take up much room, which is particularly beneficial during airport checks. Gel sachets are also a bonus for distributors. The sachets can be dispatched in air-cushioned envelopes and posted anonymously in any public post box. This also makes it easier to send the product abroad because customs checks are usually only carried out on small packets or packages.

Indications:

S-ZOL gel is intended for buccal or sublingual absorption. One S-ZOL gel sachet is adequate for one day. Half a gel sachet should be taken in the morning, before breakfast. Approximately half of an opened gel sachet should be pressed into the oral cavity and held under the tongue (sublingual) or in the cheek pouches (buccal) for at least one minute. The unabsorbed gel carrier can then be safely swallowed. The remaining gel should be used up within 12 hours. This will result in continuously high, uniform levels of the active substance, stanozolol, in the blood. S-ZOL gel can be used for up to six weeks due to the lighter load on the liver compared to the tablet or capsule form. The product can be combined with other gel products.

ACTIVE INGREDIENTS 30 mg (17α-Methyl-5α-androstano[3,2-c]pyrazol-17β-ol) Stanozolol

SEMI-ACTIVE INGREDIENTS

1000 mg BC (Burn Cuttter) L-Phenylalanine; L-Tyrosine; Caffeine as caffeine anhydrous, Norsynephrine HCL, Theobromine HCL, Yohimbine HCL and Ephedrine HCL.

INACTIVE INGREDIENTS

A proprietary Buccal Mucous Gel Base consisting of water, glycerine, xanthan gum, natural berry flavors, riboflavine, potassium sorbate as a stabilizer.